DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Protein Kinase TargetsProtein Kinase Targets
  5. /SykSyk
  6. /LanraplenibLanraplenib
Chemical structure of CAS 1800046-95-0

Lanraplenib

In Stock•Starting at $150 for 10 mg•Purity ≥ 98%
CAS No.1800046-95-0
MDL No.N/A
MFC23H25N9O
MW443.50
InChI KeyXCIGZBVOUQVIPI-UHFFFAOYSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
10 mg98%$150In Stock
100 mg98%$1202In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1800046-95-0
Product NameLanraplenib
Heavy Atom Count33Rotatable Bond Count5
Atom Stereo Count0Bond Stereo Count0
HBA10HBD2
TPSA109.730 ŲCharge0
Exact Mass443.21821Complexity1260.67
pKa7.130XLogP2.033

Related Articles

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune Diseases.

ACS medicinal chemistry letters • Vol. 11, Issue 4 • 2020
PMID: 32292557PMC: PMC7153012DOI: 10.1021/acsmedchemlett.9b00621

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact